Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Board Changes

5 Jun 2015 07:00

RNS Number : 3041P
Creston PLC
05 June 2015
 

 

Creston plc

('Creston' or the 'Group')

 

Board Changes

 

Appointment of Nigel Lingwood as Non-Executive Director

Andrew Dougal to step down from Board as Non-Executive Director

 

As part of its Board succession planning, Creston plc (LSE: CRE), the marketing communications group, today announces two changes to its Board.

 

Effective 1 July 2015, Nigel Lingwood will join the Board as Non-Executive Director. Following the AGM in September 2015, Nigel will become Senior Independent Director and Chairman of the Audit Committee.

 

Nigel has substantial executive management and listed company experience gained from the financial and commercial management of global operations.

 

Nigel's current position is as Group Finance Director of Diploma PLC, an international group of businesses supplying specialised technical products and services. Nigel has been in the role since 2001 and overseen the growth of the business, through re-investment of organic cash flow into acquisitions and existing businesses, from a FTSE Small Cap to a FTSE 250 Company.

 

Prior to this, Nigel held the role of Group Financial Controller at Unigate PLC, formerly a major European food and distribution group with an annual turnover of £3 billion.

 

Creston also announces that Andrew Dougal, following a handover to Nigel in September 2015 of the Audit Chair, will step down from the Board as Non-Executive Director at the end of November 2015. Andrew joined the Board as Non-Executive Director of Creston plc in 2006, becoming Audit Committee Chairman at the same time.

 

Richard Huntingford, Non-Executive Chairman of Creston plc, commented: "We are very pleased to welcome Nigel to the Board. Nigel has an impressive public company track record and I know his wealth of financial management, acquisition and international experience will prove invaluable to the Group."

 

Richard added: "I would also like to add my huge thanks to Andrew, on behalf of the Company and its shareholders, for the major contribution that he has made to the development of the Group during his time on the Board. He has been a continual source of sound advice and guidance and has fulfilled his role as Audit Committee chair with great diligence. We wish Andrew all the best for the future."

 

No other information is required to be disclosed pursuant to paragraph LR 9.6.13R of the Listing Rules of the Financial Conduct Authority.

 

For further information please contact:

 

Creston plc

+44 (0)20 7930 9757

Barrie Brien, Group Chief Executive

 

Kathryn Herrick, Chief Financial Officer

 

 

 

Bell Pottinger

+44 (0)20 3772 2491

Elly Williamson / Lucy Stewart

 

 

 

 

About Creston plc

Creston plc (LSE: CRE), incorporating the Creston Unlimited group offer, is a marketing communications group delivering a range of digital technology-based marketing solutions to blue-chip global clients. Encompassing consultants and discipline experts from across the industry and beyond, Creston Unlimited unlocks the power of creative collaboration to realise the opportunities that exist for brands and businesses in today's rapidly evolving world. www.creston.com / www.creston-unlimited.com  

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFERRFISIIE
Date   Source Headline
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.